Bioequivalence and Bioavailability Forum

An example of IS response. Need your helps. Shuanghe 2020-05-26 12:56
- An example of IS response. Need your helps. Sukalpa Biswas 2020-05-26 13:49
  - An example of IS response. Need your helps. Shuanghe 2020-05-26 16:32
  - An example of IS response. Need your helps. Ohlbe 2020-05-26 17:46
- An example of IS response. Need your helps. Ohlbe 2020-05-26 14:42
  - Placement of CC Helmut 2020-05-26 15:35
    - An example of IS response. Shuanghe 2020-05-26 16:32
      - An example of IS response. Ohlbe 2020-05-26 17:27
    - Placement of CC Ohlbe 2020-05-26 17:32
      - Placement of CC Helmut 2020-05-26 19:03
        
        Duplicate LLOQ and ULOQ Ohlbe 2020-05-26 19:43
        
        Duplicate LLOQ and ULOQ Helmut 2020-05-27 16:30
- An example of IS response. Need your helps. ElMaestro 2020-05-26 15:44
- An example of IS response. Need your helps. ksreekanth 2020-07-06 13:37
- Trend analysis as per recent USFDA guideline dshah 2020-08-01 07:32
  - Only for QCs; encouraged ≠ required Helmut 2020-08-01 14:13
    - Only for QCs; encouraged ≠ required dshah 2020-08-03 09:17
      - Deviation from the mean response Helmut 2020-08-07 13:28
    - Only for QCs; encouraged ≠ required Shuanghe 2020-08-03 13:56
      - Broken-stick regression Helmut 2020-08-04 18:04

dilution factor to be applied avinash 2020-08-06 06:30

Reanalysis for Pharmacokinetic Reason Obinoscopy 2020-07-16 14:30
- Reanalysis for PK Reason: Gone with the Wind Helmut 2020-07-16 15:10
  - Reanalysis for PK Reason: Gone with the Wind Ohlbe 2020-07-16 17:16
    - Reanalysis for PK Reason: Gone with the Wind Helmut 2020-07-16 18:39
      - Reanalysis for PK Reason: Gone with the Wind Ohlbe 2020-07-16 19:15
    - Reanalysis for PK Reason: Gone with the Wind Obinoscopy 2020-07-16 21:48
      - PK assessors variability Ohlbe 2020-07-16 23:07
        
        Sometimes PK assessors ≈ scientists Helmut 2020-07-17 16:11
        PK assessors variability Obinoscopy 2020-07-17 23:48
      - Reanalysis for PK Reason: Gone with the Wind ElMaestro 2020-07-16 23:19
        
        Reanalysis for PK Reason: Gone with the Wind dshah 2020-07-17 06:40
        
        Reanalysis for PK Reason: Gone with the Wind Obinoscopy 2020-07-18 00:27
        
        Reanalysis for PK Reason: Gone with the Wind dshah 2020-07-20 07:22
        
        Reanalysis for PK Reason: Gone with the Wind Obinoscopy 2020-07-20 14:12
        Positive pre-dose Ohlbe 2020-07-20 14:43
        
        Reanalysis for PK Reason: Gone with the Wind Obinoscopy 2020-07-18 00:00
        
        Reanalysis for PK Reason: Gone with the Wind ElMaestro 2020-07-20 07:49
        
        Reanalysis for PK Reason: Gone with the Wind Helmut 2020-07-20 10:52
        
        Sightly OT (for once) ElMaestro 2020-07-20 12:12
- Reanalysis for Pharmacokinetic Reason Achievwin 2020-07-27 23:47

Statistics Refresher Helmut 2004-12-04 19:52
- Statistics Refresher Achievwin 2020-07-27 23:37

Exclusion of anchor points in LBA manojbob 2020-07-03 14:31
- Exclusion of anchor points in LBA ElMaestro 2020-07-04 11:28
  - Exclusion of anchor points in LBA manojbob 2020-07-06 06:37

Reinjection Reproducibility (RR) ksreekanth 2020-07-01 18:49
- Reinjection Reproducibility (RR) Ohlbe 2020-07-02 18:35
  - Reinjection Reproducibility (RR) ksreekanth 2020-07-02 18:48
    - Reinjection Reproducibility (RR) xtianbadillo 2020-07-03 03:25

Processed Sample Stability ksreekanth 2020-05-20 13:22
- Processed Sample Stability Helmut 2020-05-20 16:29

Matrix effect during study sample analysis shreyas goswami 2020-04-09 08:18
- Matrix effect during study sample analysis ElMaestro 2020-04-09 08:40
  - Matrix effect during study sample analysis shreyas goswami 2020-04-09 12:27
- Matrix effect during study sample analysis Ohlbe 2020-04-09 14:57
  - Matrix effect during study sample analysis shreyas goswami 2020-04-10 17:29

Rejection of the standard curve Ayman Rabayah 2020-03-11 08:01
- Rejection of the standard curve ElMaestro 2020-03-11 08:55

Route of administration other than oral for concomitant medication qualityassurance 2020-02-04 11:28
- Route of administration other than oral for concomitant medication jag009 2020-02-04 19:43
- Route of administration other than oral for concomitant medication Ohlbe 2020-02-05 10:13
- Route of administration other than oral for concomitant medication Dr_Dan 2020-02-11 16:20

Metformin and linaglibtin film coated tablet Ibrahim Komeil 2019-10-19 02:18
- Metformin and linaglibtin film coated tablet hirenmistri 2019-11-28 10:51
  - Metformin and linaglibtin film coated tablet Ibrahim Komeil 2019-11-28 15:48

ISRs in Mexico and Brazil jag009 2019-02-25 21:29
- ISRs in Mexico and Brazil xtianbadillo 2019-11-21 02:31
- ISRs in Mexico and Brazil hirenmistri 2019-11-28 09:52

Evaluation of Solution stability (with post extracted matrix based samples) Ravuri sindhura 2019-11-07 12:17
- Evaluation of Solution stability (with post extracted matrix based samples) hirenmistri 2019-11-18 13:36

Crossover: samples of p1 and p2 in different batches? Ravuri sindhura 2019-09-18 19:16
- Crossover: samples of p1 and p2 in different batches? dshah 2019-09-19 09:16
  - Leads to a (pseudo-) period effect Helmut 2019-09-19 15:33
    - Leads to a (pseudo-) period effect ? Ohlbe 2019-09-19 15:50
      - Leads to a (pseudo-) period effect ? Helmut 2019-09-19 15:59
        
        Leads to a (pseudo-) period effect ? nobody 2019-09-19 16:21
        
        Almost entirely OT Helmut 2019-09-19 17:22
        
        Almost entirely OT nobody 2019-09-19 17:46
        
        Completely OT Helmut 2019-09-19 18:08
        
        Leads to a (pseudo-) period effect ? dshah 2019-09-20 07:52
        
        Leads to a (pseudo-) period effect ? nobody 2019-09-20 08:00
        Run ≠ batch? Helmut 2019-09-20 09:42
        
        Run ≠ batch Ohlbe 2019-09-20 10:37
        Run ≠ batch? dshah 2019-09-23 07:43
        
        Run ≠ batch? nobody 2019-09-23 08:36
    - Leads to a (pseudo-) period effect Ravuri sindhura 2019-09-23 13:04

Evaluation of Heparin as a potentially interfering substance Monic 2019-09-11 14:04
- Evaluation of Heparin as a potentially interfering substance ElMaestro 2019-09-11 18:06
  - Evaluation of Heparin as a potentially interfering substance nobody 2019-09-11 19:32
    - Evaluation of Heparin as a potentially interfering substance ElMaestro 2019-09-11 21:25

Admin contact
21,076 posts in 4,394 threads, 1,468 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Saturday 00:26 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses. Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz